Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
NBIX Analyst Ratings
Strong Buy
17 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
NBIX Stock 12 Month Forecast
Average Price Target
$164.45
▲(42.26% Upside)
| Highest Price Target$192.00 | Average Price Target$164.45 | Lowest Price Target$138.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
Reiterated
03/11/25
Morgan Stanley
Initiated
03/06/25
TD Cowen
Reiterated
03/05/25
Jefferies
Reiterated
03/04/25
J.P. Morgan
Reiterated
02/25/25
H.C. Wainwright
Reiterated
02/24/25
Leerink Partners
Reiterated
02/18/25
Wells Fargo
Reiterated
02/13/25
Deutsche Bank
Initiated
02/11/25
Guggenheim
Reiterated
02/10/25
UBS
$176→$154
Buy
33.22%
Upside
Reiterated
02/10/25
Neurocrine Bio. (NBIX) PT Lowered to $154 at UBSUBS analyst Ashwani Verma lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $154.00 (from $176.00) while maintaining a Buy rating.
Evercore ISI
$190
Buy
64.36%
Upside
Reiterated
02/07/25
Neurocrine (NBIX) Gets a Buy from Evercore ISI
Wedbush
$157→$147
Buy
27.16%
Upside
Reiterated
02/07/25
Wedbush Keeps Their Buy Rating on Neurocrine (NBIX)
Needham
―
Hold
―
Reiterated
02/07/25
Neurocrine's Conservative 2025 Outlook Prompts Hold Rating Amid Potential Growth Opportunities
Bank of America Securities
$184→$179
Buy
54.84%
Upside
Reiterated
02/07/25
Analysts Offer Insights on Healthcare Companies: Insmed (NASDAQ: INSM), Neurocrine (NASDAQ: NBIX) and Stryker (NYSE: SYK)We reiterate our Buy with $184 PO.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Reiterated
03/11/25
Morgan Stanley
Initiated
03/06/25
TD Cowen
Reiterated
03/05/25
Jefferies
Reiterated
03/04/25
J.P. Morgan
Reiterated
02/25/25
H.C. Wainwright
Reiterated
02/24/25
Leerink Partners
Reiterated
02/18/25
Wells Fargo
Reiterated
02/13/25
Deutsche Bank
Initiated
02/11/25
Guggenheim
Reiterated
02/10/25
UBS
$176→$154
Buy
33.22%
Upside
Reiterated
02/10/25
Neurocrine Bio. (NBIX) PT Lowered to $154 at UBSUBS analyst Ashwani Verma lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $154.00 (from $176.00) while maintaining a Buy rating.
Evercore ISI
$190
Buy
64.36%
Upside
Reiterated
02/07/25
Neurocrine (NBIX) Gets a Buy from Evercore ISI
Wedbush
$157→$147
Buy
27.16%
Upside
Reiterated
02/07/25
Wedbush Keeps Their Buy Rating on Neurocrine (NBIX)
Needham
―
Hold
―
Reiterated
02/07/25
Neurocrine's Conservative 2025 Outlook Prompts Hold Rating Amid Potential Growth Opportunities
Bank of America Securities
$184→$179
Buy
54.84%
Upside
Reiterated
02/07/25
Analysts Offer Insights on Healthcare Companies: Insmed (NASDAQ: INSM), Neurocrine (NASDAQ: NBIX) and Stryker (NYSE: SYK)We reiterate our Buy with $184 PO.
Best Analysts Covering Neurocrine
Which Analyst Should I Follow If I Want to Buy NBIX and Sell After:
1 Month
xxx
Success Rate
13/22 ratings generated profit
Average Return
+0.41%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +0.41% per trade.
3 Months
xxx
Success Rate
16/26 ratings generated profit
Average Return
+1.86%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +1.86% per trade.
1 Year
Success Rate
17/29 ratings generated profit
Average Return
+9.06%
reiterated a buy rating 4 months ago
Copying Brian Skorney's trades and holding each position for 1 Year would result in 58.62% of your transactions generating a profit, with an average return of +9.06% per trade.
2 Years
xxx
Success Rate
22/34 ratings generated profit
Average Return
+26.96%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +26.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
NBIX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
4
4
2
6
6
Buy
26
34
33
37
26
Hold
11
11
9
12
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
49
44
55
43
Each month's total comprises the sum of three months' worth of ratings.
NBIX Financial Forecast
NBIX Stock Forecast FAQ
What is NBIX’s average 12-month price target, according to analysts?
Based on analyst ratings, Neurocrine’s 12-month average price target is $164.45.
What is NBIX’s upside potential, based on the analysts’ average price target?
Neurocrine has 42.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NBIX a Buy, Sell or Hold?
Neurocrine has a consensus rating of Strong Buy which is based on 17 buy ratings, 5 hold ratings and 0 sell ratings.
What is Neurocrine’s price target?
The average price target for Neurocrine is $164.45. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $192.00 ,the lowest forecast is $138.00. The average price target represents 42.26% Increase from the current price of $115.6.
The highest analyst price target is $192.00 ,the lowest forecast is $138.00. The average price target represents 42.26% Increase from the current price of $115.6.
What do analysts say about Neurocrine?
Neurocrine’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.
How can I buy shares of NBIX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.